MedPath
FDA Approval

EXKIVITY

September 15, 2023

HUMAN PRESCRIPTION DRUG LABEL

Mobocertinib(40 mg in 1 1)

Manufacturing Establishments (6)

Lonza Tampa LLC

Takeda Pharmaceuticals America, Inc.

628112240

AndersonBrecon Inc.

Takeda Pharmaceuticals America, Inc.

053217022

Takeda Ireland Limited

Takeda Pharmaceuticals America, Inc.

988980314

Ash Stevens LLC

Takeda Pharmaceuticals America, Inc.

049265333

Eurofins Lancaster Laboratories, Inc.

Takeda Pharmaceuticals America, Inc.

069777290

Catalent Micron Technologies, Inc.

Takeda Pharmaceuticals America, Inc.

015966157

Products (1)

EXKIVITY

63020-040

NDA215310

NDA (C73594)

ORAL

September 15, 2023

Code: 39HBQ4A67LClass: ACTIBQuantity: 40 mg in 1 1
© Copyright 2025. All Rights Reserved by MedPath